AbbVie Inc. the Spinoff for 2013
AbbVie Inc (ABBV) just started trading in 2013. AbbVie is the first 'Spinoff' for Wall Street in the New Year and has separated from Abbott Labs (ABT).
AbbVie was the pharmaceutical division of Abbott Labs, so far its bounced from $34 to $35 per share. This spinoff has been in motion since 2011. Before the deal, Abbott was one of the largest healthcare companies in the world. The aging world population is going to keep popping pills made by AbbVie including the anti-inflammation drug Humira, the popular painkiller Vicodin, and cholesterol drug Niaspan.
Abbott's chairman and CEO Miles White called the event "the most transformative action" in the company's 125-history. AbbVie CEO Richard Gonzalez said that with his company's existing assets and focus on innovation "we intend to create significant value for our shareholders."
Bottom line: Time will tell if this spinoff will be successful and Wells Fargo is the first to set a price target of $33 to $34. For now add this stock to your watch list and as more information becomes available place your trading accordingly. To review the company check out their website at www.abbvie.com/
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Is Bank Lending a Concern? | Financial Sense
- Axel Merk On What's Next For The Dollar, Gold, & Stocks? | ZeroHedge
- A New Trend Emerges – Digital Gold "Gifting" Gains Popularity In China | ZeroHedge
- Crude Inventory Build Sends Oil Prices Into a Nosedive | Financial Sense
- Trump Approves TransCanada's Keystone XL Pipeline | ZeroHedge
- This New Bubble Is Even Bigger Than The Subprime Fiasco | ZeroHedge
- Death & Taxes... And Debt | ZeroHedge
The most relevant financial news and articles from the Internets
- This is the biggest mistake you can make when dressing 'business casual' | Business Insider
- Bitcoin spikes above $1,000 | Business Insider
- Here's why Canyon Barry has a... | Business Insider
- The eSports competitive video gaming market continues to grow revenues &... | Business Insider
- Here's when the F-35 will use stealth mode vs. 'beast mode' | Business Insider
- US relations with Cuba could become a bargaining chip in the healthcare debate | Business Insider
- Oil has been defying economic theory | Business Insider